Increased expression of PAD2 after repeated intracerebroventricular infusions of soluble Aβ25–35 in the Alzheimer’s disease model rat brain: Effect of memantine

Articles in the same Issue

1. The functional antagonist Met-RANTES: A modified agonist that induces differential CCR5 trafficking
2. The transcriptional regulation and cell-specific expression of the MAPK-activated protein kinase MK5
3. The anti-apoptotic activity of albumin for endothelium is inhibited by advanced glycation end products restricting intramolecular movement
4. Transcriptional profiles during the differentiation and maturation of monocyte-derived dendritic cells, analyzed using focused microarrays
5. The influence of JNK and P38 MAPK inhibition on IL-12P40 and IL-23 production depending on IL12B promoter polymorphism
6. The immunosuppressive activities of newly synthesized azaphenothiazines in human and mouse models
7. Mechanisms for the formation of membranous nanostructures in cell-to-cell communication
8. Arginine methylation analysis of the splicing-associated SR protein SFRS9/SRP30C
9. Overexpression of human osteopontin increases cell proliferation and migration in human embryo kidney-293 cells
10. The transcriptional regulation of Podocin (NPHS2) by Lmx1b and a promoter single nucleotide polymorphism
11. Molecular characterization of the niaD and pyrG genes from Penicillium camemberti, and their use as transformation markers
12. Increased expression of PAD2 after repeated intracerebroventricular infusions of soluble Aβ25–35 in the Alzheimer’s disease model rat brain: Effect of memantine